Loading…

Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients

Periampullary adenocarcinoma is a major clinical problem in high-risk patients including FAP population. A recent modification for visualizing the ampulla of Vater (AV) involves attaching a cap to the tip of the forward-viewing endoscope. Our aim was to compare the rates of complete visualization of...

Full description

Saved in:
Bibliographic Details
Published in:BMC gastroenterology 2020-07, Vol.20 (1), p.214-214, Article 214
Main Authors: Silva, Leonardo Correa, Arruda, Rondinelle Martins, Botelho, Paula Fortuci Resende, Taveira, Leonardo Nogueira, Giardina, Kelly Menezio, de Oliveira, Marco Antonio, Dias, Julia, Oliveira, Cleyton Zanardo, Fava, Gilberto, Guimarães, Denise Peixoto
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93
cites cdi_FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93
container_end_page 214
container_issue 1
container_start_page 214
container_title BMC gastroenterology
container_volume 20
creator Silva, Leonardo Correa
Arruda, Rondinelle Martins
Botelho, Paula Fortuci Resende
Taveira, Leonardo Nogueira
Giardina, Kelly Menezio
de Oliveira, Marco Antonio
Dias, Julia
Oliveira, Cleyton Zanardo
Fava, Gilberto
Guimarães, Denise Peixoto
description Periampullary adenocarcinoma is a major clinical problem in high-risk patients including FAP population. A recent modification for visualizing the ampulla of Vater (AV) involves attaching a cap to the tip of the forward-viewing endoscope. Our aim was to compare the rates of complete visualization of AV using this cap-assisted endoscopy (CAE) approach to standard forward-viewing endoscopy (FVE). We also determined: (i) the rates of complications and additional sedation; (ii) the mean time required for duodenal examination; and (iii) the reproducibility among endoscopists performing this procedure. We performed esophagogastroduodenoscopy for AV visualization in 102 > 18 years old using FVE followed by CAE. Video recordings were blinded and randomly selected for independent expert endoscopic evaluation. The complete visualization rate for AV was higher in CAE (97.0%) compared to FVE (51.0%) (p 
doi_str_mv 10.1186/s12876-020-01361-5
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_52030c42820a4da49dc0ca6b47b02d4b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A631891151</galeid><doaj_id>oai_doaj_org_article_52030c42820a4da49dc0ca6b47b02d4b</doaj_id><sourcerecordid>A631891151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93</originalsourceid><addsrcrecordid>eNptUk1r3DAUNKWhSdP-gR6KoZdenOpb9qUQliYNBHppSm_iWR-72tqWK9mB5NdHzqZLtgQdJJ7mjd6Mpig-YHSGcS2-JExqKSpEUIUwFbjir4oTzCSuCEW_Xz87HxdvU9oihGVN6JvimBLBBBXNSXGzgrGClHyarCntYELSYbwr_aCjhWRTCf04dx2UwZW_YLKxvPVphs7fw-TDkIHlxq83VfTpTznmmh2m9K44ctAl-_5pPy1uLr79XH2vrn9cXq3OryvNBZ0qmWcDQhw4QXEDteCMYSYk4RJhxw0w0lpDOAPJa4usZsIIrVvHuDTWNfS0uNrxmgBbNUbfQ7xTAbx6LIS4VhAnrzurOEEUaUZqgoBl5sZopEG0TLaIGNZmrq87rnFue2t01hGhOyA9vBn8Rq3DrZKUCUGXYT4_EcTwd7ZpUr1P2mbvBhvmpAjLcgVCDcvQT_9Bt2GOQ7ZqQTHJBMk_uketIQvwgwv5Xb2QqvNsWN1gzBfU2QuovIztvQ6DdT7XDxrIrkHHkFK0bq8RI7UES-2CpXKw1GOwFM9NH5-7s2_5lyT6ACKYx-w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424746201</pqid></control><display><type>article</type><title>Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Silva, Leonardo Correa ; Arruda, Rondinelle Martins ; Botelho, Paula Fortuci Resende ; Taveira, Leonardo Nogueira ; Giardina, Kelly Menezio ; de Oliveira, Marco Antonio ; Dias, Julia ; Oliveira, Cleyton Zanardo ; Fava, Gilberto ; Guimarães, Denise Peixoto</creator><creatorcontrib>Silva, Leonardo Correa ; Arruda, Rondinelle Martins ; Botelho, Paula Fortuci Resende ; Taveira, Leonardo Nogueira ; Giardina, Kelly Menezio ; de Oliveira, Marco Antonio ; Dias, Julia ; Oliveira, Cleyton Zanardo ; Fava, Gilberto ; Guimarães, Denise Peixoto</creatorcontrib><description>Periampullary adenocarcinoma is a major clinical problem in high-risk patients including FAP population. A recent modification for visualizing the ampulla of Vater (AV) involves attaching a cap to the tip of the forward-viewing endoscope. Our aim was to compare the rates of complete visualization of AV using this cap-assisted endoscopy (CAE) approach to standard forward-viewing endoscopy (FVE). We also determined: (i) the rates of complications and additional sedation; (ii) the mean time required for duodenal examination; and (iii) the reproducibility among endoscopists performing this procedure. We performed esophagogastroduodenoscopy for AV visualization in 102 &gt; 18 years old using FVE followed by CAE. Video recordings were blinded and randomly selected for independent expert endoscopic evaluation. The complete visualization rate for AV was higher in CAE (97.0%) compared to FVE (51.0%) (p &lt;  0.001). The additional doses of fentanyl, midazolam, and propofol required for CAE were 0.05, 1.9 and 36.3 mg. in 0.9, 24.5, and 77.5% patients, respectively. The mean time of duodenal examination for AV visualization was lower on CAE compared to FVE (1.41 vs. 1.95 min, p &lt;  0.001). Scopolamine was used in 34 FVE and 24 CAE, with no association to AV complete visualization rates (p = 0.30 and p = 0.14). Three more ampullary adenomas were detected using CAE compared to FVE. Cap displacement occurred in one patient, and there was no observed adverse effect of the additional sedatives used. Kappa values for agreement between endoscopists ranged from 0.60 to 0.85. CAE is feasible, reproducible and safe, with a higher success rate for complete visualization compared to FVE. ClinicalTrials.gov , NCT02867826 , 16 August 2016.</description><identifier>ISSN: 1471-230X</identifier><identifier>EISSN: 1471-230X</identifier><identifier>DOI: 10.1186/s12876-020-01361-5</identifier><identifier>PMID: 32646369</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adenocarcinoma ; Adolescent ; Ampulla of Vater ; Ampulla of Vater - diagnostic imaging ; Ampullary adenoma ; Ampullary carcinoma ; Anesthesia ; Biliary tract cancer ; Cancer ; Cap-assisted endoscopy ; Care and treatment ; Common Bile Duct Neoplasms - diagnostic imaging ; Duodenal Neoplasms - diagnostic imaging ; Endoscopes ; Endoscopy ; Endoscopy, Digestive System ; Esophagogastroduodenoscopy ; Fentanyl ; Forward-viewing endoscopy ; Gastroenterology ; Humans ; Midazolam ; Patients ; Propofol ; Reproducibility of Results ; Risk groups ; Scopolamine ; Sedatives ; Software ; Studies ; Surveillance ; Visualization</subject><ispartof>BMC gastroenterology, 2020-07, Vol.20 (1), p.214-214, Article 214</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93</citedby><cites>FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93</cites><orcidid>0000-0002-0568-7038</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346639/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2424746201?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32646369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva, Leonardo Correa</creatorcontrib><creatorcontrib>Arruda, Rondinelle Martins</creatorcontrib><creatorcontrib>Botelho, Paula Fortuci Resende</creatorcontrib><creatorcontrib>Taveira, Leonardo Nogueira</creatorcontrib><creatorcontrib>Giardina, Kelly Menezio</creatorcontrib><creatorcontrib>de Oliveira, Marco Antonio</creatorcontrib><creatorcontrib>Dias, Julia</creatorcontrib><creatorcontrib>Oliveira, Cleyton Zanardo</creatorcontrib><creatorcontrib>Fava, Gilberto</creatorcontrib><creatorcontrib>Guimarães, Denise Peixoto</creatorcontrib><title>Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients</title><title>BMC gastroenterology</title><addtitle>BMC Gastroenterol</addtitle><description>Periampullary adenocarcinoma is a major clinical problem in high-risk patients including FAP population. A recent modification for visualizing the ampulla of Vater (AV) involves attaching a cap to the tip of the forward-viewing endoscope. Our aim was to compare the rates of complete visualization of AV using this cap-assisted endoscopy (CAE) approach to standard forward-viewing endoscopy (FVE). We also determined: (i) the rates of complications and additional sedation; (ii) the mean time required for duodenal examination; and (iii) the reproducibility among endoscopists performing this procedure. We performed esophagogastroduodenoscopy for AV visualization in 102 &gt; 18 years old using FVE followed by CAE. Video recordings were blinded and randomly selected for independent expert endoscopic evaluation. The complete visualization rate for AV was higher in CAE (97.0%) compared to FVE (51.0%) (p &lt;  0.001). The additional doses of fentanyl, midazolam, and propofol required for CAE were 0.05, 1.9 and 36.3 mg. in 0.9, 24.5, and 77.5% patients, respectively. The mean time of duodenal examination for AV visualization was lower on CAE compared to FVE (1.41 vs. 1.95 min, p &lt;  0.001). Scopolamine was used in 34 FVE and 24 CAE, with no association to AV complete visualization rates (p = 0.30 and p = 0.14). Three more ampullary adenomas were detected using CAE compared to FVE. Cap displacement occurred in one patient, and there was no observed adverse effect of the additional sedatives used. Kappa values for agreement between endoscopists ranged from 0.60 to 0.85. CAE is feasible, reproducible and safe, with a higher success rate for complete visualization compared to FVE. ClinicalTrials.gov , NCT02867826 , 16 August 2016.</description><subject>Adenocarcinoma</subject><subject>Adolescent</subject><subject>Ampulla of Vater</subject><subject>Ampulla of Vater - diagnostic imaging</subject><subject>Ampullary adenoma</subject><subject>Ampullary carcinoma</subject><subject>Anesthesia</subject><subject>Biliary tract cancer</subject><subject>Cancer</subject><subject>Cap-assisted endoscopy</subject><subject>Care and treatment</subject><subject>Common Bile Duct Neoplasms - diagnostic imaging</subject><subject>Duodenal Neoplasms - diagnostic imaging</subject><subject>Endoscopes</subject><subject>Endoscopy</subject><subject>Endoscopy, Digestive System</subject><subject>Esophagogastroduodenoscopy</subject><subject>Fentanyl</subject><subject>Forward-viewing endoscopy</subject><subject>Gastroenterology</subject><subject>Humans</subject><subject>Midazolam</subject><subject>Patients</subject><subject>Propofol</subject><subject>Reproducibility of Results</subject><subject>Risk groups</subject><subject>Scopolamine</subject><subject>Sedatives</subject><subject>Software</subject><subject>Studies</subject><subject>Surveillance</subject><subject>Visualization</subject><issn>1471-230X</issn><issn>1471-230X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1r3DAUNKWhSdP-gR6KoZdenOpb9qUQliYNBHppSm_iWR-72tqWK9mB5NdHzqZLtgQdJJ7mjd6Mpig-YHSGcS2-JExqKSpEUIUwFbjir4oTzCSuCEW_Xz87HxdvU9oihGVN6JvimBLBBBXNSXGzgrGClHyarCntYELSYbwr_aCjhWRTCf04dx2UwZW_YLKxvPVphs7fw-TDkIHlxq83VfTpTznmmh2m9K44ctAl-_5pPy1uLr79XH2vrn9cXq3OryvNBZ0qmWcDQhw4QXEDteCMYSYk4RJhxw0w0lpDOAPJa4usZsIIrVvHuDTWNfS0uNrxmgBbNUbfQ7xTAbx6LIS4VhAnrzurOEEUaUZqgoBl5sZopEG0TLaIGNZmrq87rnFue2t01hGhOyA9vBn8Rq3DrZKUCUGXYT4_EcTwd7ZpUr1P2mbvBhvmpAjLcgVCDcvQT_9Bt2GOQ7ZqQTHJBMk_uketIQvwgwv5Xb2QqvNsWN1gzBfU2QuovIztvQ6DdT7XDxrIrkHHkFK0bq8RI7UES-2CpXKw1GOwFM9NH5-7s2_5lyT6ACKYx-w</recordid><startdate>20200709</startdate><enddate>20200709</enddate><creator>Silva, Leonardo Correa</creator><creator>Arruda, Rondinelle Martins</creator><creator>Botelho, Paula Fortuci Resende</creator><creator>Taveira, Leonardo Nogueira</creator><creator>Giardina, Kelly Menezio</creator><creator>de Oliveira, Marco Antonio</creator><creator>Dias, Julia</creator><creator>Oliveira, Cleyton Zanardo</creator><creator>Fava, Gilberto</creator><creator>Guimarães, Denise Peixoto</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0568-7038</orcidid></search><sort><creationdate>20200709</creationdate><title>Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients</title><author>Silva, Leonardo Correa ; Arruda, Rondinelle Martins ; Botelho, Paula Fortuci Resende ; Taveira, Leonardo Nogueira ; Giardina, Kelly Menezio ; de Oliveira, Marco Antonio ; Dias, Julia ; Oliveira, Cleyton Zanardo ; Fava, Gilberto ; Guimarães, Denise Peixoto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma</topic><topic>Adolescent</topic><topic>Ampulla of Vater</topic><topic>Ampulla of Vater - diagnostic imaging</topic><topic>Ampullary adenoma</topic><topic>Ampullary carcinoma</topic><topic>Anesthesia</topic><topic>Biliary tract cancer</topic><topic>Cancer</topic><topic>Cap-assisted endoscopy</topic><topic>Care and treatment</topic><topic>Common Bile Duct Neoplasms - diagnostic imaging</topic><topic>Duodenal Neoplasms - diagnostic imaging</topic><topic>Endoscopes</topic><topic>Endoscopy</topic><topic>Endoscopy, Digestive System</topic><topic>Esophagogastroduodenoscopy</topic><topic>Fentanyl</topic><topic>Forward-viewing endoscopy</topic><topic>Gastroenterology</topic><topic>Humans</topic><topic>Midazolam</topic><topic>Patients</topic><topic>Propofol</topic><topic>Reproducibility of Results</topic><topic>Risk groups</topic><topic>Scopolamine</topic><topic>Sedatives</topic><topic>Software</topic><topic>Studies</topic><topic>Surveillance</topic><topic>Visualization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, Leonardo Correa</creatorcontrib><creatorcontrib>Arruda, Rondinelle Martins</creatorcontrib><creatorcontrib>Botelho, Paula Fortuci Resende</creatorcontrib><creatorcontrib>Taveira, Leonardo Nogueira</creatorcontrib><creatorcontrib>Giardina, Kelly Menezio</creatorcontrib><creatorcontrib>de Oliveira, Marco Antonio</creatorcontrib><creatorcontrib>Dias, Julia</creatorcontrib><creatorcontrib>Oliveira, Cleyton Zanardo</creatorcontrib><creatorcontrib>Fava, Gilberto</creatorcontrib><creatorcontrib>Guimarães, Denise Peixoto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, Leonardo Correa</au><au>Arruda, Rondinelle Martins</au><au>Botelho, Paula Fortuci Resende</au><au>Taveira, Leonardo Nogueira</au><au>Giardina, Kelly Menezio</au><au>de Oliveira, Marco Antonio</au><au>Dias, Julia</au><au>Oliveira, Cleyton Zanardo</au><au>Fava, Gilberto</au><au>Guimarães, Denise Peixoto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients</atitle><jtitle>BMC gastroenterology</jtitle><addtitle>BMC Gastroenterol</addtitle><date>2020-07-09</date><risdate>2020</risdate><volume>20</volume><issue>1</issue><spage>214</spage><epage>214</epage><pages>214-214</pages><artnum>214</artnum><issn>1471-230X</issn><eissn>1471-230X</eissn><abstract>Periampullary adenocarcinoma is a major clinical problem in high-risk patients including FAP population. A recent modification for visualizing the ampulla of Vater (AV) involves attaching a cap to the tip of the forward-viewing endoscope. Our aim was to compare the rates of complete visualization of AV using this cap-assisted endoscopy (CAE) approach to standard forward-viewing endoscopy (FVE). We also determined: (i) the rates of complications and additional sedation; (ii) the mean time required for duodenal examination; and (iii) the reproducibility among endoscopists performing this procedure. We performed esophagogastroduodenoscopy for AV visualization in 102 &gt; 18 years old using FVE followed by CAE. Video recordings were blinded and randomly selected for independent expert endoscopic evaluation. The complete visualization rate for AV was higher in CAE (97.0%) compared to FVE (51.0%) (p &lt;  0.001). The additional doses of fentanyl, midazolam, and propofol required for CAE were 0.05, 1.9 and 36.3 mg. in 0.9, 24.5, and 77.5% patients, respectively. The mean time of duodenal examination for AV visualization was lower on CAE compared to FVE (1.41 vs. 1.95 min, p &lt;  0.001). Scopolamine was used in 34 FVE and 24 CAE, with no association to AV complete visualization rates (p = 0.30 and p = 0.14). Three more ampullary adenomas were detected using CAE compared to FVE. Cap displacement occurred in one patient, and there was no observed adverse effect of the additional sedatives used. Kappa values for agreement between endoscopists ranged from 0.60 to 0.85. CAE is feasible, reproducible and safe, with a higher success rate for complete visualization compared to FVE. ClinicalTrials.gov , NCT02867826 , 16 August 2016.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>32646369</pmid><doi>10.1186/s12876-020-01361-5</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0568-7038</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-230X
ispartof BMC gastroenterology, 2020-07, Vol.20 (1), p.214-214, Article 214
issn 1471-230X
1471-230X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_52030c42820a4da49dc0ca6b47b02d4b
source PubMed (Medline); Publicly Available Content Database
subjects Adenocarcinoma
Adolescent
Ampulla of Vater
Ampulla of Vater - diagnostic imaging
Ampullary adenoma
Ampullary carcinoma
Anesthesia
Biliary tract cancer
Cancer
Cap-assisted endoscopy
Care and treatment
Common Bile Duct Neoplasms - diagnostic imaging
Duodenal Neoplasms - diagnostic imaging
Endoscopes
Endoscopy
Endoscopy, Digestive System
Esophagogastroduodenoscopy
Fentanyl
Forward-viewing endoscopy
Gastroenterology
Humans
Midazolam
Patients
Propofol
Reproducibility of Results
Risk groups
Scopolamine
Sedatives
Software
Studies
Surveillance
Visualization
title Cap-assisted endoscopy increases ampulla of Vater visualization in high-risk patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T23%3A53%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cap-assisted%20endoscopy%20increases%20ampulla%20of%20Vater%20visualization%20in%20high-risk%20patients&rft.jtitle=BMC%20gastroenterology&rft.au=Silva,%20Leonardo%20Correa&rft.date=2020-07-09&rft.volume=20&rft.issue=1&rft.spage=214&rft.epage=214&rft.pages=214-214&rft.artnum=214&rft.issn=1471-230X&rft.eissn=1471-230X&rft_id=info:doi/10.1186/s12876-020-01361-5&rft_dat=%3Cgale_doaj_%3EA631891151%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c563t-7230a22faf6319a86544146725701f5da42bed254a758e0ec46d6ccbf457def93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2424746201&rft_id=info:pmid/32646369&rft_galeid=A631891151&rfr_iscdi=true